Open the News about your Business

US Stock: Johnson & Johnson

Apr 25, 2024Finance0

Company: Johnson & JohnsonBloomberg ticker: JNJ USMarket cap: US$383,813mBackground: Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being.
 World Class Benchmarking of Johnson & Johnson

  • Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 1 was better than its Growth rank of 4
  • Profitability rank of 1 was up compared to the prior period’s 2nd rank
  • This is World Class performance compared to peers
  • Growth rank of 4 was up compared to the prior period’s 7th rank
  • This is above average performance compared to peers

    • More By This Author:US Stock: Pfizer
    European Stock: AstraZeneca
    Asian Stock: Sinopharm Group

    Reviews

    • Total Score 0%
    User rating: 0.00% ( 0
    votes )
    Top FSC Democrat says stablecoin bill is imminent

    Related articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *